⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10833302 | 0.76 | — | — | |
| SCHEMBL193595 | 0.67 | — | — | |
| Bromide SCHEMBL14829309 | 0.67 | — | — | |
| SCHEMBL4077679 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL4450262 | 0.65 | — | — | |
| SCHEMBL4453867 | 0.63 | — | — | |
| SCHEMBL255876 | 0.62 | — | — | |
| SCHEMBL1254660 | 0.60 | — | — | |
| SCHEMBL30923519 | 0.60 | — | — | |
| Charcoal, Activated SCHEMBL29797978 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4577529-A2 | COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2 | F. Hoffmann-La Roche AG (CH) | 2025-07-02 | — | — | EP | claimed |
| WO-2024042146-A2 | COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2 | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-29 | — | — | WO | claimed |
| EP-4577529-A2 | COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2 | F. Hoffmann-La Roche AG (CH) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024042146-A2 | COVALENT FLUORESCENT PROBES FOR CANNABINOID RECEPTOR 2 | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-29 | — | — | WO | disclosed |
| US-9180123-B2 | N-link hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150182513-A1 | N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER INC. (US) | 2015-07-02 | — | — | US | disclosed |
| US-9018384-B2 | N-link hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2015-04-28 | — | — | US | disclosed |
| US-20140343031-A1 | N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER INC. (US) | 2014-11-20 | — | — | US | disclosed |
| EP-2512474-B1 | N-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | PFIZER (US) | 2014-11-05 | — | — | EP | disclosed |
| US-8846933-B2 | N-link hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140128363-A1 | N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER (US) | 2014-05-08 | — | — | US | disclosed |
| US-8664401-B2 | N-linked hydroxamic acid derivatives useful as antibacterial agents | PFIZER INC. (US) | 2014-03-04 | — | — | US | disclosed |
| EP-2512474-A1 | N-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | Pfizer Inc. (US) | 2012-10-24 | — | — | EP | disclosed |
| US-20120258948-A1 | N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents | PFIZER INC. | 2012-10-11 | — | — | US | disclosed |
| WO-2011073845-A1 | N-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 2011-06-23 | — | — | WO | disclosed |